Selective SIRPα blockade reverses tumor T cell exclusion and overcomes cancer immunotherapy resistance - Université de Rennes Accéder directement au contenu
Article Dans Une Revue Journal of Clinical Investigation Année : 2020

Selective SIRPα blockade reverses tumor T cell exclusion and overcomes cancer immunotherapy resistance

Bernard Vanhove
  • Fonction : Auteur
  • PersonId : 865774

Résumé

T cell exclusion causes resistance to cancer immunotherapies via immune checkpoint blockade (ICB). Myeloid cells contribute to resistance by expressing signal regulatory protein-α (SIRPα), an inhibitory membrane receptor that interacts with ubiquitous receptor CD47 to control macrophage phagocytosis in the tumor microenvironment. Although CD47/SIRPα-targeting drugs have been assessed in preclinical models, the therapeutic benefit of selectively blocking SIRPα, and not SIRPγ/CD47, in humans remains unknown. We report a potent synergy between selective SIRPα blockade and ICB in increasing memory T cell responses and reverting exclusion in syngeneic and orthotopic tumor models. Selective SIRPα blockade stimulated tumor nest T cell recruitment by restoring murine and human macrophage chemokine secretion and increased anti-tumor T cell responses by promoting tumor-antigen crosspresentation by dendritic cells. However, nonselective SIRPα/SIRPγ blockade targeting CD47 impaired human T cell activation, proliferation, and endothelial transmigration. Selective SIRPα inhibition opens an attractive avenue to overcoming ICB resistance in patients with elevated myeloid cell infiltration in solid tumors.

Dates et versions

hal-03001660 , version 1 (12-11-2020)

Identifiants

Citer

Vanessa Gauttier, Sabrina Pengam, Justine Durand, Kevin Biteau, Caroline Mary, et al.. Selective SIRPα blockade reverses tumor T cell exclusion and overcomes cancer immunotherapy resistance. Journal of Clinical Investigation, 2020, 130 (11), pp.6109-6123. ⟨10.1172/JCI135528⟩. ⟨hal-03001660⟩
78 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More